hemophilia
FDA Approves Qfitlia for Hemophilia A or B
The FDA approved Qfitlia for adults and children 12 years of age and older with hemophilia A or B, with or without ...
APRIL 7, 2025
$1 Million Health Plan Savings for Hemophilia Gene Therapy Projected
A gene therapy product approved for adults with hemophilia B may increase initial costs for health plans but can ...
DECEMBER 17, 2024
New Developments in Hemophilia Gene Therapy
Hemophilia is an X chromosome–linked genetic bleeding disorder caused by absent or defective clotting factor, ...
NOVEMBER 29, 2024
New Developments in Hemophilia Gene Therapy
Hemophilia is an X chromosome–linked genetic bleeding disorder caused by absent or defective clotting factor, ...
MAY 30, 2024
Octapharma USA Grant Helps Hemophiliac Man Climb the World’s Seven Summits
Octapharma’s support ties into its goal of creatively demonstrating that patients with bleeding disorders, ...
NOVEMBER 1, 2017
Gene Therapy for Hemophilia Gains Ground
Gene therapy for hemophilia A and B is finally scoring some clinically meaningful successes.
AUGUST 15, 2016
Less Factor = More Savings, Good Outcomes in Hemophilia
Option Care home infusion program saved a projected $21,165 annually per patient.
JULY 26, 2016
